carbostyril has been researched along with Carotid Artery Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ametamey, SM; Borel, N; Krämer, SD; Meletta, R; Mu, L; Müller Herde, A; Rancic, Z; Schibli, R; Slavik, R | 1 |
Arima, H; Hirabayashi, M; Miura, Y; Murase, T; Nagasaki, H; Oiso, Y; Sugimura, Y; Tachikawa, K; Yokoi, H | 1 |
2 other study(ies) available for carbostyril and Carotid Artery Diseases
Article | Year |
---|---|
Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [
Topics: Adamantane; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers; Carbon Radioisotopes; Carotid Artery Diseases; Gene Expression Regulation; Humans; Male; Mice; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Quinolones; Radioactive Tracers; Receptor, Cannabinoid, CB2 | 2017 |
Altered cardiovascular regulation in arginine vasopressin-overexpressing transgenic rat.
Topics: Adaptation, Physiological; Animals; Animals, Genetically Modified; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Carotid Artery Diseases; Hemorrhage; Hemostasis; Male; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin | 2003 |